ArticleHaematologica2017

Targeting metabolism and survival in chronic lymphocytic leukemia and Richter syndrome cells by a novel NF-κB inhibitor.

Tiziana Vaisitti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.